XML 35 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Capital Stock and Stock Compensation
12 Months Ended
Nov. 24, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
13.
Capital Stock and Stock Compensation
 
We account for our stock-based employee and director compensation plans in accordance with ASC
718,
Compensation – Stock Compensation
. ASC
718
requires recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements over the period the employee is required to perform the services in exchange for the award (presumptively the vesting period) which we recognize on a straight-line basis. Compensation expense related to restricted stock and stock options included in selling, general and administrative expenses in our consolidated statements of income for fiscal
2018,
2017
and
2016
was as follows:
 
   
2018
   
2017
   
2016
 
                         
Stock based compensation expense
  $
1,133
    $
1,028
    $
903
 
 
Incentive Stock Compensation Plans
 
On
April 
14,
2010,
our shareholders approved the Bassett Furniture Industries, Incorporated
2010
Stock Incentive Plan which was amended and restated effective
January 13, 2016 (
the
“2010
Plan”). All present and future non-employee directors, key employees and outside consultants for the Company are eligible to receive incentive awards under the
2010
Plan. Our Organization, Compensation and Nominating Committee (the “Compensation Committee”) selects eligible key employees and outside consultants to receive awards under the
2010
Plan in its discretion. Our Board of Directors or any committee designated by the Board of Directors selects eligible non-employee directors to receive awards under the
2010
Plan in its discretion.
1,250,000
 shares of common stock are reserved for issuance under the
2010
Plan as amended. Participants
may
receive the following types of incentive awards under the
2010
Plan: stock options, stock appreciation rights, payment shares, restricted stock, restricted stock units and performance shares. Stock options
may
be incentive stock options or non-qualified stock options. Stock appreciation rights
may
be granted in tandem with stock options or as a freestanding award. Non-employee directors and outside consultants are eligible to receive restricted stock and restricted stock units only. We expect to issue new common stock upon the exercise of options.
 
The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. The risk free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method. Forfeitures are recognized as they occur. We utilize the simplified method to determine the expected life of our options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns.
 
Stock Options
 
There were
no
new grants of options made in
2018,
2017
or
2016.
 
Changes in the outstanding options under our plans during the year ended
November 24, 2018
were as follows:
 
   
Number of Shares
   
Weighted
Average
Exercise Price
Per Share
 
                 
Outstanding at November 25, 2017
   
11,750
    $
8.02
 
Granted
   
-
     
-
 
Exercised
   
(3,400
)    
8.02
 
Forfeited/Expired
   
-
   
 
-
 
Outstanding at November 24, 2018
   
8,350
     
8.02
 
Exercisable at November 24, 2018
   
8,350
    $
8.02
 
 
All remaining options outstanding at
November 24, 2018
are exercisable at
$8.02
per share with a remaining contractual life of
2.6
years and an aggregate intrinsic value of
$102.
There were
no
non-vested options outstanding under our plans during the year ended
November 24, 2018.
 
Additional information regarding activity in our stock options during fiscal
2018,
2017
and
2016
is as follows:
 
   
2018
   
2017
   
2016
 
                         
Total intrinsic value of options exercised
  $
75
    $
564
    $
124
 
Total cash received from the exercise of options
   
27
     
310
     
114
 
Excess tax benefits recognized in income tax expense upon the exercise of options
   
16
     
188
     
41
 
 
 
Restricted Shares
 
Changes in the outstanding non-vested restricted shares during the year ended
November 24, 2018
were as follows:
 
   
Number of Shares
   
Weighted
Average Grant
Date Fair
Value Per
Share
 
                 
Non-vested restricted shares outstanding at November 25, 2017
   
99,138
    $
23.87
 
Granted
   
45,036
     
34.41
 
Vested
   
(63,138
)    
20.92
 
Forfeited
   
-
     
-
 
Non-vested restricted shares outstanding at November 24, 2018
   
81,036
    $
32.03
 
 
Restricted share awards granted in fiscal
2018
included the grant of
36,000
shares on
January 11, 2018
which were subject to a performance condition as well as a service condition. The performance condition was based on a measure of the Company’s operating cash flow for
2018
and has now been satisfied. The awards will remain subject to an additional
two
-year service requirement and will vest on the
third
anniversary of the grant. The remaining grants for
2018
consisted of
6,036
restricted shares granted to our non-employee directors on
March 8, 2018
which will vest on the
first
anniversary of the grant, and
3,000
restricted shares granted to an employee on
October 2, 2018
which will vest on the
third
anniversary of the grant.
 
During fiscal
2018,
63,138
restricted shares were vested and released, of which
56,600
shares had been granted to employees and
6,538
shares to directors. Of the shares released to employees,
19,810
shares were withheld by the Company to cover withholding taxes of
$674.
During fiscal
2017
and
2016,
21,210
shares and
2,940
shares, respectively, were withheld to cover withholding taxes of
$641
and
$77,
respectively, arising from the vesting of restricted shares. During fiscal
2018,
2017
and
2016,
excess tax benefits of
$207,
$366
and
$46,
respectively, were recognized within income tax expense upon the release of vested shares.
 
Additional information regarding our outstanding non-vested restricted shares at
November 24, 2018
is as follows:
 
   
 
 
 
 
 
 
 
 
Remaining
 
   
Restricted
   
Share Value
   
Restriction
 
Grant
 
Shares
   
at Grant Date
   
Period
 
Date
 
Outstanding
   
Per Share
   
(Years)
 
                       
                       
January 10, 2017
   
36,000
    $
29.05
   
1.1
 
January 11, 2018
   
36,000
     
35.75
   
2.1
 
March 8, 2018
   
6,036
     
33.07
   
0.3
 
October 2, 2018
   
3,000
     
20.97
   
2.9
 
     
81,036
     
 
   
 
 
 
Unrecognized compensation cost related to these non-vested restricted shares at
November 24, 2018
is
$1,627,
substantially all of which is expected to be recognized over approximately a
two
year period.
 
Employee Stock Purchase Plan
 
In
2000,
we adopted and implemented an Employee Stock Purchase Plan (
“2000
ESPP”) that allows eligible employees to purchase a limited number of shares of our stock at
85%
of market value. Under the
2000
ESPP we sold
8,502
shares to employees in fiscal
2016,
which resulted in an immaterial amount of compensation expense. The
2000
ESPP reached the cumulative number of shares authorized for purchase under the plan during the
third
quarter of fiscal
2016.
 
In
March
of
2017
we adopted and implemented the
2017
Employee Stock Purchase Plan (
“2017
ESPP”) that allows eligible employees to purchase a limited number of shares of our stock at
85%
of market value. Under the
2017
ESPP we sold
14,967
and
6,275
shares to employees during fiscal
2018
and
2017,
respectively, which resulted in an immaterial amount of compensation expense. There are
228,758
shares remaining available for sale under the
2017
ESPP at
November 24, 2018.